A Novel Mechanics-based Intervention to Improve Post-stroke Stability
2 other identifiers
interventional
54
1 country
1
Brief Summary
The purpose of this study is to determine whether a novel treadmill training intervention can improve the gait stabilization strategy used by individuals who have experienced a stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Apr 2017
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 4, 2016
CompletedFirst Posted
Study publicly available on registry
November 15, 2016
CompletedStudy Start
First participant enrolled
April 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedResults Posted
Study results publicly available
July 28, 2021
CompletedJune 3, 2024
December 1, 2023
3 years
November 4, 2016
July 6, 2021
December 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Partial Correlation Between Pelvis Displacement and Paretic Step Width During Gait (Change From Baseline)
A custom measure that quantifies the strength of the relationship between body mechanics and foot placement. This measure falls within a relatively narrow range among neurologically intact controls, but is substantially reduced in some individuals who have experienced a stroke, indicating a reduced ability to stabilize their gait pattern. This measure relates the mechanical state of the body at the start of each step (mediolateral pelvis displacement and velocity of the pelvis relative to the stance foot) to the step width at the end of the step. Specifically, the partial linear correlation between pelvis displacement and step width was calculated, accounting for variation in pelvis velocity. The change in this measure relative to baseline is calculated at four time points (after 4, 8, 12, and 24 weeks).
baseline, 4-weeks, 8-weeks, 12-weeks, 24-weeks
Secondary Outcomes (5)
Functional Gait Assessment (Change From Baseline)
baseline, 4-weeks, 8-weeks, 12-weeks, 24-weeks
Activities-specific Balance Confidence Scale (Change From Baseline)
baseline, 4-weeks, 8-weeks, 12-weeks, 24-weeks
10-meter Walk Test (Change From Baseline)
baseline, 4-weeks, 8-weeks, 12-weeks, 24-weeks
Fall Incidence
6 months (during 12 week follow-up period)
Fear of Falling
6 months (at completion of 12-week Follow-up period)
Study Arms (3)
Error reduction
EXPERIMENTALParticipants will complete a 12-week training program, in which they practice walking on a treadmill for 30-minutes during twice-weekly training sessions. During these sessions, participants will interface with a custom-built force-field able to exert mediolateral forces on the legs, which will be in "error reduction" mode. This training period will be followed by a 12-week follow-up period. Five assessment sessions will be interspersed throughout this total 24-week period.
Error augmentation
EXPERIMENTALParticipants will complete a 12-week training program, in which they practice walking on a treadmill for 30-minutes during twice-weekly training sessions. During these sessions, participants will interface with a custom-built force-field able to exert mediolateral forces on the legs, which will be in "error augmentation" mode. This training period will be followed by a 12-week follow-up period. Five assessment sessions will be interspersed throughout this total 24-week period.
Activity matched control
SHAM COMPARATORParticipants will complete a 12-week training program, in which they practice walking on a treadmill for 30-minutes during twice-weekly training sessions. During these sessions, participants will interface with a custom-built force-field able to exert mediolateral forces on the legs, which will be in "transparent" mode. This training period will be followed by a 12-week follow-up period. Five assessment sessions will be interspersed throughout this total 24-week period.
Interventions
During training sessions, a custom-built force-field will exert forces on the legs while participants walk. These forces will push the legs toward mechanically-appropriate mediolateral locations, having the effect of reducing the errors in foot placement that are often present among individuals who have experienced a stroke.
During training sessions, a custom-built force-field will exert forces on the legs while participants walk. These forces will push the legs away from mechanically-appropriate mediolateral locations, having the effect of amplifying the errors in foot placement that are often present among individuals who have experienced a stroke.
During training sessions, participants will interface with a custom-built force-field while they walk. The force-field will essentially get out of the way, producing minimal forces on the legs, and having no direct effect on the errors in foot placement that are often present among individuals who have experienced a stroke.
Eligibility Criteria
You may qualify if:
- At least 21 years old
- Experience of a stroke 6 months prior to participation
- Preferred overground gait speed of at least 0.2 m/s
- Ability to walk at self-selected speed for 3 minutes without a cane or walker
- Provision of informed consent.
You may not qualify if:
- Resting heart rate above 110 beats/min
- Resting blood pressure higher than 200/110 mm Hg
- History of congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living
- Preexisting neurological disorders or dementia
- History of major head trauma
- Legal blindness or severe visual impairment
- Life expectancy \<1 yr; 8)
- History of deep vein thrombosis or pulmonary embolism within 6 months
- Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
- Orthopedic injuries or conditions (e.g. joint replacements) in the lower extremities with the potential to alter the gait pattern.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, 29401-5799, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The overall dropout rate of this study was increased by the research shutdown with the coronavirus pandemic.
Results Point of Contact
- Title
- Jesse Dean
- Organization
- Ralph H. Johnson VAMC / MUSC
Study Officials
- PRINCIPAL INVESTIGATOR
Jesse C. Dean, PhD
Ralph H. Johnson VA Medical Center, Charleston, SC
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 4, 2016
First Posted
November 15, 2016
Study Start
April 1, 2017
Primary Completion
March 31, 2020
Study Completion
March 31, 2020
Last Updated
June 3, 2024
Results First Posted
July 28, 2021
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
De-identified, anonymized data sets will be available to other investigators or members of the public upon request. These data sets will be made available upon completion of data collection, processing, and initial statistical analyses. The data sets will include physiological measures related to functional mobility, as well as the results of clinical tests.